Professor Matthew Meyerson
Meet Matthew, Co-Team Lead of OPTIMISTICC
Matthew is Professor of Genetics and Medicine at the Dana-Farber Cancer Institute and Harvard Medical School, an Institute Member of the Broad Institute, and Co-Director of the Dana-Farber Center for Cancer Genomics.
Among other honors, he has been awarded the Paul Marks Prize in Cancer Research from Memorial Sloan-Kettering Cancer Center and the Team Science Award from the American Association for Cancer Research.
Matthew’s research focus includes genomic analysis of human lung cancers, genome-inspired cancer drug discovery, and the cancer microbiome. One major discovery was somatic mutations in the epidermal growth factor gene, EGFR, that predict response to EGFR kinase inhibitors, a discovery that has propelled research in personalized medicine. The Meyerson laboratory developed the computational subtraction approach for discovery of novel disease-causing microbes and discovered the association of Fusobacterium with colorectal cancer.